Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antipsychotic Risk Examined In NEJM; Did FDA Judge Atypicals Unfairly?

Executive Summary

Conventional antipsychotic medications should not be prescribed as replacements for atypical products despite an FDA public health advisory about the newer agents because conventional medications appear to have higher mortality in elderly patients, an article in the Dec. 1 New England Journal of Medicine concludes

You may also be interested in...



FDA Stance On Antidepressant Warnings Unchanged By NIMH Suicide Findings

A National Institute of Mental Health-funded study showing no increased risk of suicide with newer antidepressants does not change FDA's stance on the need for warnings about suicidality for the drug class

FDA Stance On Antidepressant Warnings Unchanged By NIMH Suicide Findings

A National Institute of Mental Health-funded study showing no increased risk of suicide with newer antidepressants does not change FDA's stance on the need for warnings about suicidality for the drug class

FDA Drug Risk Communication Should Include Drug Benefit Info, PhRMA Says

FDA risk communication materials should include information about a drug's benefits to avoid scaring patients away from their medications, the Pharmaceutical Research & Manufacturers of America said

Related Content

Topics

UsernamePublicRestriction

Register

PS046611

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel